Mesenchymal stromal cell therapy for liver diseases

Mohammed Alfaifi, Young Woo Eom, Philip N. Newsome, Soon Koo Baik

Research output: Contribution to journalReview articlepeer-review

51 Citations (Scopus)

Abstract

The therapeutic potential of mesenchymal stromal cells (MSCs) in the treatment of liver fibrosis is predominantly based on their immunosuppressive properties, and their ability to secrete various trophic factors. This potential has been investigated in clinical and preclinical studies. Although the therapeutic mechanisms of MSC transplantation are still not fully characterised, accumulating evidence has revealed that various trophic factors secreted by MSCs play key therapeutic roles in regeneration by alleviating inflammation, apoptosis, and fibrosis as well as stimulating angiogenesis and tissue regeneration in damaged liver. In this review, we summarise the safety, efficacy, potential transplantation routes and therapeutic effects of MSCs in patients with liver fibrosis. We also discuss some of the key strategies to enhance the functionality of MSCs, which include sorting and/or priming with factors such as cytokines, as well as genetic engineering.

Original languageEnglish
Pages (from-to)1272-1285
Number of pages14
JournalJournal of Hepatology
Volume68
Issue number6
DOIs
Publication statusPublished - 2018 Jun

Bibliographical note

Funding Information:
MA is supported by a grant from the Saudi Arabian Cultural Bureau. PNN is supported by the National Institute of Health Research (NIHR) Birmingham Liver Biomedical Research Unit (BRU). The views expressed are those of the authors and not necessarily reflect those of the NHS, the NIHR or the Department of Health.

Funding Information:
YWE and SKB were supported by a grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (HI15C2364, HI17C1365), and a Basic Science Research Program and a Medical Research Center Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (NRF-2017R1D1A1A02019212 and -2017R1A5A2015369, respectively).

Publisher Copyright:
© 2018 European Association for the Study of the Liver

All Science Journal Classification (ASJC) codes

  • Hepatology

Fingerprint Dive into the research topics of 'Mesenchymal stromal cell therapy for liver diseases'. Together they form a unique fingerprint.

Cite this